• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过全自动HER2荧光原位杂交(FISH)分析乳腺癌中的HER2状态:两种免疫组织化学检测与手工FISH的比较

Analysis of HER2 status in breast carcinoma by fully automated HER2 fluorescence in situ hybridization (FISH): comparison of two immunohistochemical tests and manual FISH.

作者信息

Yoon Nara, Do In-Gu, Cho Eun Yoon

机构信息

Department of Pathology, Samsung Medical Center, Sungkyunkwan University College of Medicine, Seoul, Korea.

出版信息

APMIS. 2014 Sep;122(9):755-60. doi: 10.1111/apm.12215. Epub 2013 Dec 20.

DOI:10.1111/apm.12215
PMID:24372629
Abstract

Easy and accurate HER2 testing is essential when considering the prognostic and predictive significance of HER2 in breast cancer. The use of a fully automated, quantitative FISH assay would be helpful to detect HER2 amplification in breast cancer tissue specimens with reduced inter-laboratory variability. We compared the concordance of HER2 status as assessed by an automated FISH staining system to manual FISH testing. Using 60 formalin-fixed paraffin-embedded breast carcinoma specimens, we assessed HER2 immunoexpression with two antibodies (DAKO HercepTest and CB11). In addition, HER2 status was evaluated with automated FISH using the Leica FISH System for BOND and a manual FISH using the Abbott PathVysion DNA Probe Kit. All but one specimen were successfully stained using both FISH methods. When the data were divided into two groups according to HER2/CEP17 ratio, positive and negative, the results from both the automated and manual FISH techniques were identical for all 59 evaluable specimens. The HER2 and CEP17 copy numbers and HER2/CEP17 ratio showed great agreement between both FISH methods. The automated FISH technique was interpretable with signal intensity similar to those of the manual FISH technique. In contrast with manual FISH, the automated FISH technique showed well-preserved architecture due to low membrane digestion. HER2 immunohistochemistry and FISH results showed substantial significant agreement (κ = 1.0, p < 0.001). HER2 status can be reliably determined using a fully automated HER2 FISH system with high concordance to the well-established manual FISH method. Because of stable signal intensity and high staining quality, the automated FISH technique may be more appropriate than manual FISH for routine applications.

摘要

在考虑HER2在乳腺癌中的预后和预测意义时,简便准确的HER2检测至关重要。使用全自动定量FISH检测有助于在乳腺癌组织标本中检测HER2扩增,同时降低实验室间的变异性。我们比较了通过自动FISH染色系统评估的HER2状态与手工FISH检测结果的一致性。我们使用60份福尔马林固定石蜡包埋的乳腺癌标本,用两种抗体(DAKO HercepTest和CB11)评估HER2免疫表达。此外,使用徕卡BOND FISH系统进行自动FISH检测HER2状态,并用雅培PathVysion DNA探针试剂盒进行手工FISH检测。除一份标本外,其余所有标本均成功用两种FISH方法染色。当根据HER2/CEP17比值将数据分为阳性和阴性两组时,对于所有59份可评估标本,自动和手工FISH技术的结果均相同。两种FISH方法在HER2和CEP17拷贝数以及HER2/CEP17比值方面显示出高度一致性。自动FISH技术的信号强度与手工FISH技术相似,易于解读。与手工FISH相比,自动FISH技术由于膜消化程度低,组织结构保存良好。HER2免疫组化和FISH结果显示出高度显著一致性(κ = 1.0,p < 0.001)。使用全自动HER2 FISH系统能够可靠地确定HER2状态,与成熟的手工FISH方法具有高度一致性。由于信号强度稳定且染色质量高,自动FISH技术可能比手工FISH更适合常规应用。

相似文献

1
Analysis of HER2 status in breast carcinoma by fully automated HER2 fluorescence in situ hybridization (FISH): comparison of two immunohistochemical tests and manual FISH.通过全自动HER2荧光原位杂交(FISH)分析乳腺癌中的HER2状态:两种免疫组织化学检测与手工FISH的比较
APMIS. 2014 Sep;122(9):755-60. doi: 10.1111/apm.12215. Epub 2013 Dec 20.
2
Automated processing of fluorescence in-situ hybridization slides for HER2 testing in breast and gastro-esophageal carcinomas.用于乳腺癌和胃食管癌中HER2检测的荧光原位杂交玻片的自动化处理
Exp Mol Pathol. 2014 Aug;97(1):116-9. doi: 10.1016/j.yexmp.2014.06.003. Epub 2014 Jun 11.
3
Comparison of automated and manual determination of HER2 status in breast cancer for diagnostic use: a comparative methodological study using the Ventana BenchMark automated staining system and manual tests.用于诊断的乳腺癌中HER2状态自动测定与手动测定的比较:一项使用Ventana BenchMark自动染色系统和手动检测的比较方法学研究
Int J Oncol. 2004 Oct;25(4):929-35.
4
HER2 amplification status in breast cancer: a comparison between immunohistochemical staining and fluorescence in situ hybridisation using manual and automated quantitative image analysis scoring techniques.乳腺癌中HER2扩增状态:使用手动和自动定量图像分析评分技术对免疫组织化学染色和荧光原位杂交的比较
J Clin Pathol. 2005 Jul;58(7):710-4. doi: 10.1136/jcp.2004.023424.
5
An immunohistochemical and fluorescence in situ hybridization-based comparison between the Oracle HER2 Bond Immunohistochemical System, Dako HercepTest, and Vysis PathVysion HER2 FISH using both commercially validated and modified ASCO/CAP and United Kingdom HER2 IHC scoring guidelines.基于免疫组织化学和荧光原位杂交技术,使用商业验证的以及修改后的美国临床肿瘤学会/美国病理学家协会(ASCO/CAP)和英国HER2免疫组化评分指南,对Oracle HER2 Bond免疫组织化学系统、Dako HercepTest和Vysis PathVysion HER2荧光原位杂交技术进行比较。
Appl Immunohistochem Mol Morphol. 2010 Dec;18(6):489-93. doi: 10.1097/PAI.0b013e3181e3d893.
6
Evaluation of the HER2 amplification status in oesophageal adenocarcinoma by conventional and automated FISH: a tissue microarray study.评估食管腺癌中 HER2 扩增状态的常规和自动化 FISH:组织微阵列研究。
J Clin Pathol. 2014 Jan;67(1):26-32. doi: 10.1136/jclinpath-2013-201570. Epub 2013 Sep 16.
7
Comparison of Pathvysion and Poseidon HER2 FISH assays in measuring HER2 amplification in breast cancer: a validation study.Pathvysion 与 Poseidon HER2 FISH 检测法在乳腺癌 HER2 扩增检测中的比较:一项验证性研究。
J Clin Pathol. 2010 Apr;63(4):341-6. doi: 10.1136/jcp.2009.066852. Epub 2009 Dec 3.
8
Chromogenic in situ hybridization (CISH) to detect HER2 gene amplification in breast and gastric cancer: comparison with immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH).显色原位杂交(CISH)检测乳腺癌和胃癌中 HER2 基因扩增:与免疫组织化学(IHC)和荧光原位杂交(FISH)的比较。
Pathol Int. 2012 Nov;62(11):728-34. doi: 10.1111/j.1440-1827.2012.02862.x.
9
HER2 assessment by immunohistochemical analysis and fluorescence in situ hybridization: comparison of HercepTest and PathVysion commercial assays.通过免疫组织化学分析和荧光原位杂交进行HER2评估:HercepTest和PathVysion商业检测方法的比较
Am J Clin Pathol. 2002 Jun;117(6):935-43. doi: 10.1309/3643-F955-7Q6B-EWWL.
10
Breast cancer HER2 equivocal cases: is there an alternative to FISH testing? A pilot study using two different antibodies sequentially.乳腺癌HER2结果不明确的病例:是否有替代荧光原位杂交(FISH)检测的方法?一项序贯使用两种不同抗体的初步研究。
Isr Med Assoc J. 2010 Jun;12(6):353-6.

引用本文的文献

1
The effect of an alternative chromosome 17 probe on fluorescence hybridization for the assessment of HER2 amplification in invasive breast cancer.一种替代的17号染色体探针在荧光杂交评估浸润性乳腺癌HER2基因扩增中的作用。
Exp Ther Med. 2019 Sep;18(3):2095-2103. doi: 10.3892/etm.2019.7756. Epub 2019 Jul 9.
2
Automated detection of the HER2 gene amplification status in Fluorescence in situ hybridization images for the diagnostics of cancer tissues.自动化检测荧光原位杂交图像中 HER2 基因扩增状态,用于癌症组织的诊断。
Sci Rep. 2019 Jun 3;9(1):8231. doi: 10.1038/s41598-019-44643-z.
3
Validation of break-apart and fusion MYC probes using a digital fluorescence in situ hybridization capture and imaging system.
使用数字荧光原位杂交捕获和成像系统对断裂-分离和融合MYC探针进行验证。
J Pathol Inform. 2016 May 4;7:20. doi: 10.4103/2153-3539.181764. eCollection 2016.